Munoz-Antonia T - Search Results

1

Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.

Meng S, Chen Z, Munoz-Antonia T, Wu J. Meng S, et al. Biochem J. 2005 Oct 1;391(Pt 1):143-51. doi: 10.1042/BJ20050229. Biochem J. 2005. PMID: 15952937 Free PMC article.

2

Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor.

Cunnick JM, Dorsey JF, Munoz-Antonia T, Mei L, Wu J. Cunnick JM, et al. J Biol Chem. 2000 May 5;275(18):13842-8. doi: 10.1074/jbc.275.18.13842. J Biol Chem. 2000. PMID: 10788507 Free article.

3

Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.

Adnane J, Bizouarn FA, Chen Z, Ohkanda J, Hamilton AD, Munoz-Antonia T, Sebti SM. Adnane J, et al. Oncogene. 2000 Nov 16;19(48):5525-33. doi: 10.1038/sj.onc.1203920. Oncogene. 2000. PMID: 11114730

4

Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer.

Gordian E, Li J, Pevzner Y, Mediavilla-Varela M, Luddy K, Ohaegbulam K, Daniel KG, Haura EB, Muñoz-Antonia T. Gordian E, et al. PLoS One. 2014 Dec 11;9(12):e114131. doi: 10.1371/journal.pone.0114131. eCollection 2014. PLoS One. 2014. PMID: 25501935 Free PMC article.

5

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam KC, Muñoz-Antonia T, Qu X, Eschrich S, Uramoto H, Tanaka F, Nasarre P, Gemmill RM, Roche J, Drabkin HA, Haura EB. Yoshida T, et al. PLoS One. 2016 Jan 20;11(1):e0147344. doi: 10.1371/journal.pone.0147344. eCollection 2016. PLoS One. 2016. PMID: 26789630 Free PMC article.

6

RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1.

Adnane J, Seijo E, Chen Z, Bizouarn F, Leal M, Sebti SM, Muñoz-Antonia T. Adnane J, et al. J Biol Chem. 2002 Mar 8;277(10):8500-7. doi: 10.1074/jbc.M104367200. Epub 2001 Dec 11. J Biol Chem. 2002. PMID: 11741970 Free article.

7

A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression.

Muñoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S. Muñoz-Antonia T, et al. Cancer Res. 1996 Nov 1;56(21):4831-5. Cancer Res. 1996. PMID: 8895728

8

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model.

Sarcar B, Gimbrone NT, Wright G, Remsing Rix LL, Gordian ER, Rix U, Chiappori AA, Reuther GW, Santiago-Cardona PG, Muñoz-Antonia T, Cress WD. Sarcar B, et al. Among authors: munoz antonia t. FEBS Open Bio. 2019 Oct;9(10):1689-1704. doi: 10.1002/2211-5463.12702. Epub 2019 Sep 7. FEBS Open Bio. 2019. PMID: 31314158 Free PMC article.

9

Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.

Jackson RJ, Antonia SJ, Wright KL, Moon NS, Nepveu A, Muñoz-Antonia T. Jackson RJ, et al. Arch Biochem Biophys. 1999 Nov 15;371(2):290-300. doi: 10.1006/abbi.1999.1459. Arch Biochem Biophys. 1999. PMID: 10545217

10

Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.

Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T. Muro-Cacho CA, et al. Clin Cancer Res. 2001 Jun;7(6):1618-26. Clin Cancer Res. 2001. PMID: 11410498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters